Mayo Clinic research has identified a powerful new way to improve the prediction of a patient's long-term cardiovascular disease risk by enhancing a routinely performed imaging test with artificial intelligence (AI). Heart ...
Mar 30, 2026
0
3
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs) in the glomerular mesangium, leading to mesangial cell proliferation, enhanced ...
Mar 30, 2026
0
2
The UK has recently seen a resurgence of meningococcal B (MenB) disease, with a cluster of cases in Kent described as "unprecedented" by the health secretary, Wes Streeting. As attention turns from the current MenB outbreak ...
Mar 30, 2026
0
2
What is the optimal way to learn something new? In a JNeurosci paper, John Byrne and colleagues, from the University of Texas Health Science Center at Houston, bring us a step closer to answering this question by using Aplysia, ...
Mar 30, 2026
0
3
The prolonged armed conflict in Colombia has had a significant impact on tuberculosis (TB) incidence and mortality. This is revealed by a study led by the Barcelona Institute for Global Health (ISGlobal), which aimed to develop ...
Mar 30, 2026
0
2
Dr. Jacquelyn Means knew that being pregnant in her late 30s would be challenging.
Mar 30, 2026
0
3
Researchers at the University of Hawaiʻi at Mānoa are using artificial intelligence and machine learning (AI/ML) to better understand what improves outcomes for individuals receiving treatment for substance use disorders.
Mar 30, 2026
0
3
In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valve replacement (TAVR), the investigational Emboliner device performed comparably to the ...
Mar 30, 2026
0
2
Preterm birth is a major cause of neonatal illness and death, especially among women with a history of premature delivery. Researchers in Japan explored whether taking probiotics early in pregnancy could help reduce the risk ...
Mar 30, 2026
0
1
An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in blood sugar and weight ...
Mar 30, 2026
0
2
